Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,345.00up ₹9.60 (0.72%)BSE ₹1,338.50
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,335.40.
29 Oct: open ₹1,343.50, high ₹1,352.80, low ₹1,336.10
52-week range of traded prices to 29 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,264 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.10
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 20,20,77261.4% delivered
Dr. Reddy's Laboratories results
123 filed, newest first. Page 2 of 3.
Jul 2015
May 2015
Jan 2015
Oct 2014
Jul 2014
May 2014
13 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2014 as follows: Net Sales of Rs. 253227 lacs for the quarter ending on 31-MAR-2014 against Rs. 216090 lacs for the quarter ending on 31-MAR-2013. Net Profit / (Loss) of of Rs. 47143 lacs for the quarter ending on 31-MAR-2014 against Rs. 37815 lacs for the quarter ending on 31-MAR-2013.13 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2014 as follows: Net Sales of Rs. 949572 lacs for year ending on 31-MAR-2014 against Rs. 807434 lacs for the year ending on 31-MAR-2013. Net Profit / (Loss) of Rs. 193284 lacs for the year ending on 31-MAR-2014 against Rs. 126547 lacs for the year ending on 31-MAR-2013.
Apr 2014
8 Apr · Results
Dr. Reddy's Laboratories Limited has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2014 instead of unaudited/audited quarterly financial results for the quarter ended March 31, 2014. the above referred audited annual financial results of the Company for the year ended March 31, 2014 would be announced within 60 days from the end of the relevant financial year.
Feb 2014
11 Feb · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2013 as follows: Net Sales of Rs. 254711 lacs for the quarter ending on 31-DEC-2013 against Rs. 269182 lacs and Rs. 213725 lacs for the quarters ending on 30-SEP-2013 and 31-DEC-2012 respectively. Net Profit / (Loss) of Rs. 62317 lacs for the quarter ending on 31-DEC-2013 against Rs. 77338 lacs and Rs. 34664 lacs for the quarters ending on 30-SEP-2013 and 31-DEC-2012 respectively.
Oct 2013
Jul 2013
May 2013
14 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2013 as follows: Net Sales of Rs. 807434 lacs for year ending on 31-MAR-2013 against Rs. 660378 lacs for the year ending on 31-MAR-2012. Net Profit / (Loss) of Rs. 126547 lacs for the year ending on 31-MAR-2013 against Rs. 91236 lacs for the year ending on 31-MAR-2012.14 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2013 as follows: Net Sales of Rs. 216090 lacs for the quarter ending on 31-MAR-2013 against Rs. 174871 lacs for the quarter ending on 31-MAR-2012. Net Profit / (Loss) of of Rs. 37815 lacs for the quarter ending on 31-MAR-2013 against Rs. 21179 lacs for the quarter ending on 31-MAR-2012.
Feb 2013
14 Feb · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2012 as follows: Net Sales of Rs. 212460 lacs for the quarter ending on 31-DEC-2012 against Rs. 209011 lacs and Rs. 156680 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively. Net Profit / (Loss) of Rs. 34664 lacs for the quarter ending on 31-DEC-2012 against Rs. 36303 lacs and Rs. 10803 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively.
Oct 2012
30 Oct · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2012 as follows: Net Sales of Rs. 204129 lacs for the quarter ending on 30-SEP-2012 against Rs. 174755 lacs and Rs. 161256 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively. Net Profit / (Loss) of Rs. 36303 lacs for the quarter ending on 30-SEP-2012 against Rs. 17766 lacs and Rs. 13850 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively.
Jul 2012
May 2012
11 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2012 as follows: Net Sales of Rs. 660378 lacs for year ending on 31-MAR-2012 against Rs. 521804 lacs for the year ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 91236 lacs for the year ending on 31-MAR-2012 against Rs. 89331 lacs for the year ending on 31-MAR-2011.
Feb 2012
3 Feb · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 156680 lacs for quarter ending on 31-DEC-2011 against Rs. 136479 lacs for the quarter ending on 31-DEC-2010. Net Profit / (Loss) of Rs. 10803 lacs for the quarter ending on 31-DEC-2011 against Rs. 26277 lacs for the quarter ending on 31-DEC-2010.
Oct 2011
25 Oct · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 161256 lacs for quarter ending on 30-SEP-2011 against Rs. 127832 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 13850 lacs for the quarter ending on 30-SEP-2011 against Rs. 22020 lacs for the quarter ending on 30-SEP-2010.
Jul 2011
20 Jul · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 167571 lacs for quarter ending on 30-JUN-2011 against Rs. 125622 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 45405 lacs for the quarter ending on 30-JUN-2011 against Rs. 24448 lacs for the quarter ending on 30-JUN-2010.
May 2011
13 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 521804 lacs for year ending on 31-MAR-2011 against Rs. 440113 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 89331 lacs for the year ending on 31-MAR-2011 against Rs. 84608 lacs for the year ending on 31-MAR-2010.
Apr 2011
8 Apr · Results
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2011 instead of unaudited/ audited quarterly financial results for the quarter ended March 31, 2011. In this respect, the audited annual financial results of the Company for the year ended March 31, 2011 would be announced within 60 days from the end of the relevant financial year.
Jan 2011
25 Jan · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 136479 lacs for quarter ending on 31-DEC-2010 against Rs. 103136 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 26277 lacs for the quarter ending on 31-DEC-2010 against Rs. 16842 lacs for the quarter ending on 31-DEC-2009.
Oct 2010
23 Oct · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 127832 lacs for quarter ending on 30-SEP-2010 against Rs. 107322 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 22020 lacs for the quarter ending on 30-SEP-2010 against Rs. 19706 lacs for the quarter ending on 30-SEP-2009.
Jul 2010
22 Jul · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 125622 lacs for quarter ending on 30-JUN-2010 against Rs. 114417 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 24448 lacs for the quarter ending on 30-JUN-2010 against Rs. 22744 lacs for the quarter ending on 30-JUN-2009.
May 2010
6 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 685164 lacs for year ending on 31-MAR-2010 against Rs. 679037 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 35147 lacs for the year ending on 31-MAR-2010 against Rs. (91724) lacs for the year ending on 31-MAR-2009.6 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 440113 lacs for year ending on 31-MAR-2010 against Rs. 399963 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 84608 lacs for the year ending on 31-MAR-2010 against Rs. 56089 lacs for the year ending on 31-MAR-2009.6 May · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 115237 lacs for quarter ending on 31-MAR-2010 against Rs. 104583 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 25316 lacs for the quarter ending on 31-MAR-2010 against Rs. 15617 lacs for the quarter ending on 31-MAR-2009.
Apr 2010
6 Apr · Results
Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2010 instead of unaudited/ audited quarterly financial results for the quarter ended March 31, 2010.
Jan 2010
20 Jan · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 170355 lacs for quarter ending on 31-DEC-2009 against Rs. 180499 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. (23307) lacs for the quarter ending on 31-DEC-2009 against Rs. 15916 lacs for the quarter ending on 31-DEC-2008.20 Jan · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 103136 lacs for quarter ending on 31-DEC-2009 against Rs. 95212 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 16842 lacs for the quarter ending on 31-DEC-2009 against Rs. 10367 lacs for the quarter ending on 31-DEC-2008.
Oct 2009
23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 357921 lacs for half year ending on 30-SEP-2009 against Rs. 305720 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 47874 lacs for the half year ending on 30-SEP-2009 against Rs. 17860 lacs for the half year ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 221739 lacs for half year ending on 30-SEP-2009 against Rs. 200168 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 42450 lacs for the half year ending on 30-SEP-2009 against Rs. 30105 lacs for the half year ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 180043 lacs for quarter ending on 30-SEP-2009 against Rs. 157594 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 23985 lacs for the quarter ending on 30-SEP-2009 against Rs. 8664 lacs for the quarter ending on 30-SEP-2008.23 Oct · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 107322 lacs for quarter ending on 30-SEP-2009 against Rs. 92243 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19706 lacs for the quarter ending on 30-SEP-2009 against Rs. 9101 lacs for the quarter ending on 30-SEP-2008.
Jul 2009
21 Jul · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 114417 lacs for quarter ending on 30-JUN-2009 against Rs. 107925 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 22744 lacs for the quarter ending on 30-JUN-2009 against Rs. 21005 lacs for the quarter ending on 30-JUN-2008.21 Jul · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 177878 lacs for quarter ending on 30-JUN-2009 against Rs. 148126 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 23889 lacs for the quarter ending on 30-JUN-2009 against Rs. 9197 lacs for the quarter ending on 30-JUN-2008.
May 2009
18 May · Results
Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 104583 lacs for quarter ending on 31-MAR-2009 against Rs. 98887 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 15617 lacs for the quarter ending on 31-MAR-2009 against Rs. 16226 lacs for the quarter ending on 31-MAR-2008.